Published in Gastroenterology on November 07, 2012
Seated Evaluation of Anorectal funcTion by High Resolution Anorectal Manometry (SEAT) | NCT02633592
American Gastroenterological Association technical review on constipation. Gastroenterology (2013) 3.27
An update on anorectal disorders for gastroenterologists. Gastroenterology (2013) 1.37
Comparison of rectal balloon expulsion test in seated and left lateral positions. Neurogastroenterol Motil (2013) 0.98
Diagnostic testing for fecal incontinence. Clin Colon Rectal Surg (2014) 0.90
How to Perform and Interpret a High-resolution Anorectal Manometry Test. J Neurogastroenterol Motil (2016) 0.90
Diagnostic accuracy study of anorectal manometry for diagnosis of dyssynergic defecation. Gut (2015) 0.89
The diagnostic value of a digital rectal examination compared with high-resolution anorectal manometry in patients with chronic constipation and fecal incontinence. Am J Gastroenterol (2015) 0.87
Functional Anorectal Disorders. Gastroenterology (2016) 0.85
Advances in motility testing--current and novel approaches. Nat Rev Gastroenterol Hepatol (2013) 0.85
The incidence rate and characteristics of clinically diagnosed defecatory disorders in the community. Neurogastroenterol Motil (2016) 0.82
Irritable bowel syndrome-diarrhea: characterization of genotype by exome sequencing, and phenotypes of bile acid synthesis and colonic transit. Am J Physiol Gastrointest Liver Physiol (2013) 0.80
High-resolution Anorectal Manometry for Identifying Defecatory Disorders and Rectal Structural Abnormalities in Women. Clin Gastroenterol Hepatol (2016) 0.80
Can high-resolution anorectal manometry shed new light on defecatory disorders? Gastroenterology (2012) 0.79
Relationship Among Anal Sphincter Injury, Patulous Anal Canal, and Anal Pressures in Patients With Anorectal Disorders. Clin Gastroenterol Hepatol (2015) 0.79
Diagnosis and Treatment of Dyssynergic Defecation. J Neurogastroenterol Motil (2016) 0.78
Determinants and clinical impact of pressure drift in manoscan anorectal high resolution manometry system. Neurogastroenterol Motil (2016) 0.75
Low-volume versus high-volume initiated trans-anal irrigation therapy in adults with chronic constipation: study protocol for a randomised controlled trial. Trials (2017) 0.75
Reproducibility of high-definition (3D) manometry and its agreement with high-resolution (2D) manometry in women with fecal incontinence. Neurogastroenterol Motil (2016) 0.75
Management of pelvic floor disorders: biofeedback and more. Curr Treat Options Gastroenterol (2014) 0.75
Habit training versus habit training with direct visual biofeedback in adults with chronic constipation: study protocol for a randomised controlled trial. Trials (2017) 0.75
Resting anal pressure, not outlet obstruction or transit, predicts healthcare utilization in chronic constipation: a retrospective cohort analysis. Neurogastroenterol Motil (2015) 0.75
Manometric comparison of anorectal function after posterior vaginal compartment repair with and without mesh. Chin Med J (Engl) (2015) 0.75
Digital Rectal Examination and Balloon Expulsion Test in the Study of Defecatory Disorders: Are They Suitable as Screening or Excluding Tests? Can J Gastroenterol Hepatol (2016) 0.75
What Is New in Rome IV. J Neurogastroenterol Motil (2017) 0.75
High-resolution anorectal manometry: An expensive hobby or worth every penny? Neurogastroenterol Motil (2017) 0.75
Functional anorectal disorders. Gastroenterology (2006) 2.80
Obstructive defecation: a failure of rectoanal coordination. Am J Gastroenterol (1998) 2.31
Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. Gastroenterology (2005) 2.05
Rectal hyposensitivity. Am J Gastroenterol (2006) 1.86
Minimum standards of anorectal manometry. Neurogastroenterol Motil (2002) 1.66
Investigation of the utility of colorectal function tests and Rome II criteria in dyssynergic defecation (Anismus). Neurogastroenterol Motil (2004) 1.65
Predictive value of the balloon expulsion test for excluding the diagnosis of pelvic floor dyssynergia in constipation. Gastroenterology (2004) 1.62
A new questionnaire for constipation and faecal incontinence. Aliment Pharmacol Ther (2004) 1.58
Influence of body position and stool characteristics on defecation in humans. Am J Gastroenterol (2006) 1.58
Colonic transit scintigraphy labeled activated charcoal compared with ion exchange pellets. J Nucl Med (1997) 1.54
Digital rectal examination is a useful tool for identifying patients with dyssynergia. Clin Gastroenterol Hepatol (2010) 1.43
Phenotypic variation in functional disorders of defecation. Gastroenterology (2005) 1.41
Normal values for high-resolution anorectal manometry in healthy women: effects of age and significance of rectoanal gradient. Am J Gastroenterol (2012) 1.39
Validation of symptom-based diagnostic criteria for irritable bowel syndrome: a critical review. Am J Gastroenterol (2010) 1.23
Anorectal disorders. Am J Gastroenterol (2010) 1.20
Phenotypic variation of colonic motor functions in chronic constipation. Gastroenterology (2009) 1.20
A clinical prediction model to estimate risk for 30-day adverse events in emergency department patients with symptomatic atrial fibrillation. Ann Emerg Med (2010) 1.15
Diagnosis and treatment of pelvic floor disorders: what's new and what to do. Gastroenterology (2010) 1.06
Clinical value of symptom assessment in patients with constipation. Dis Colon Rectum (1999) 1.04
Insights into normal and disordered bowel habits from bowel diaries. Am J Gastroenterol (2007) 1.04
Relationships between pelvic floor symptoms and function in irritable bowel syndrome. Neurogastroenterol Motil (2010) 0.91
Constipation does not develop following elective hysterectomy: a prospective, controlled study. Neurogastroenterol Motil (2009) 0.88
Evidence for pelvic floor dyssynergia in patients with irritable bowel syndrome. Dis Colon Rectum (2010) 0.88
Effects of vaginal hysterectomy on anorectal sensorimotor functions--a prospective study. Neurogastroenterol Motil (2011) 0.82
The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol (2011) 3.92
Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis (2007) 3.83
Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology (2009) 3.73
A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology (2013) 3.56
Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology (2008) 3.52
The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. Gastroenterology (2004) 3.50
Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. Gastroenterology (2006) 2.87
The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology (2002) 2.78
Prevalence and burden of fecal incontinence: a population-based study in women. Gastroenterology (2005) 2.64
Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol (2009) 2.55
Trends in the identification and clinical features of celiac disease in a North American community, 1950-2001. Clin Gastroenterol Hepatol (2003) 2.47
Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study. Clin Gastroenterol Hepatol (2007) 2.44
Endoscopic skipping of the distal terminal ileum in Crohn's disease can lead to negative results from ileocolonoscopy. Clin Gastroenterol Hepatol (2012) 2.41
Impact of lymph node staging on therapy of esophageal carcinoma. Gastroenterology (2003) 2.35
Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis (2005) 2.32
Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome. Gastroenterology (2007) 2.30
Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial. Gastrointest Endosc (2008) 2.30
A study of candidate genotypes associated with dyspepsia in a U.S. community. Am J Gastroenterol (2006) 2.30
The digital rectal examination: a multicenter survey of physicians' and students' perceptions and practice patterns. Am J Gastroenterol (2012) 2.19
Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology (2007) 2.14
Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea. Clin Gastroenterol Hepatol (2012) 2.13
Mucosal atrophy in celiac disease: extent of involvement, correlation with clinical presentation, and response to treatment. Clin Gastroenterol Hepatol (2007) 2.07
The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut (2006) 1.97
Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol (2006) 1.94
Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol (2008) 1.93
Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. Gastroenterology (2006) 1.91
Contribution of endogenous glucagon-like peptide 1 to glucose metabolism after Roux-en-Y gastric bypass. Diabetes (2013) 1.90
Drawing a blank in functional dyspepsia? Gastroenterology (2006) 1.89
Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study. Am J Gastroenterol (2009) 1.88
Utility of biomarkers in prediction of response to ablative therapy in Barrett's esophagus. Gastroenterology (2008) 1.87
Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin Gastroenterol Hepatol (2009) 1.87
Age-related changes in the pancreas identified by EUS: a prospective evaluation. Gastrointest Endosc (2005) 1.86
Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol (2004) 1.86
Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study. Mayo Clin Proc (2004) 1.85
Diet and functional gastrointestinal disorders: a population-based case-control study. Am J Gastroenterol (2005) 1.84
Obstetric trauma, pelvic floor injury and fecal incontinence: a population-based case-control study. Am J Gastroenterol (2012) 1.82
Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine. Gastroenterology (2002) 1.80
Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures. Clin Gastroenterol Hepatol (2012) 1.80
The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology (2008) 1.77
A community-based, controlled study of the epidemiology and pathophysiology of dyspepsia. Clin Gastroenterol Hepatol (2004) 1.75
Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease. Clin Gastroenterol Hepatol (2008) 1.70
Effect of exercise treadmill testing and stress imaging on the triage of patients with chest pain: CHEER substudy. Mayo Clin Proc (2005) 1.69
Increasing incidence of celiac disease in a North American population. Am J Gastroenterol (2013) 1.69
A prospective, randomized, double-blind, placebo-controlled trial of endoscopic steroid injection therapy for recalcitrant esophageal peptic strictures. Am J Gastroenterol (2005) 1.64
Subsite-specific risk factors for esophageal and gastric adenocarcinoma. Am J Gastroenterol (2007) 1.63
Incidence of pelvic floor repair after hysterectomy: A population-based cohort study. Am J Obstet Gynecol (2007) 1.56
Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. Gastroenterology (2010) 1.54
Continuous 12-lead electrocardiographic monitoring in an emergency department chest pain unit: an assessment of potential clinical effect. Ann Emerg Med (2003) 1.54
Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis. Gastroenterology (2010) 1.53
Effect of alginate on satiation, appetite, gastric function, and selected gut satiety hormones in overweight and obesity. Obesity (Silver Spring) (2009) 1.52
Symptoms and quality of life in community women with fecal incontinence. Clin Gastroenterol Hepatol (2006) 1.52
Diurnal pattern of insulin action in type 1 diabetes: implications for a closed-loop system. Diabetes (2013) 1.51
Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study. Gastroenterology (2006) 1.51
Factors that predict relief from upper abdominal pain after cholecystectomy. Clin Gastroenterol Hepatol (2011) 1.50
Use of a screening tool to determine nonadherent behavior in inflammatory bowel disease. Am J Gastroenterol (2012) 1.47
A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome. Am J Gastroenterol (2009) 1.47
Psychosocial distress and somatic symptoms in community subjects with irritable bowel syndrome: a psychological component is the rule. Am J Gastroenterol (2009) 1.46
Gastric sensory and motor dysfunction in adolescents with functional dyspepsia. J Pediatr (2005) 1.46
Diurnal pattern to insulin secretion and insulin action in healthy individuals. Diabetes (2012) 1.46
Epidemiology, mechanisms, and management of diabetic gastroparesis. Clin Gastroenterol Hepatol (2010) 1.46
American Gastroenterological Association medical position statement on constipation. Gastroenterology (2013) 1.44
Bowel disturbances are the most important risk factors for late onset fecal incontinence: a population-based case-control study in women. Gastroenterology (2010) 1.43
Clinical features and outcome of patients with inflammatory bowel disease who use narcotics: a case-control study. Inflamm Bowel Dis (2009) 1.42
Phenotypic variation in functional disorders of defecation. Gastroenterology (2005) 1.41
Impact of gastroesophageal reflux on survival in the community. Am J Gastroenterol (2007) 1.40
Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome. Clin Gastroenterol Hepatol (2008) 1.39
Risk factors for fecal incontinence: a population-based study in women. Am J Gastroenterol (2006) 1.39
Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people. Gastroenterology (2006) 1.39
Normal values for high-resolution anorectal manometry in healthy women: effects of age and significance of rectoanal gradient. Am J Gastroenterol (2012) 1.39
Predictors of family risk for celiac disease: a population-based study. Clin Gastroenterol Hepatol (2008) 1.38
Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls. Am J Physiol Gastrointest Liver Physiol (2011) 1.38
Relationship between clinical features and gastric emptying disturbances in diabetes mellitus. Clin Endocrinol (Oxf) (2008) 1.37
The epidemiology of Clostridium difficile infection in children: a population-based study. Clin Infect Dis (2013) 1.36
Is there an association between GNbeta3-C825T genotype and lower functional gastrointestinal disorders? Gastroenterology (2006) 1.35
Surgery in a population-based cohort of Crohn's disease from Olmsted County, Minnesota (1970-2004). Am J Gastroenterol (2012) 1.34
Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation. Am J Gastroenterol (2011) 1.33
Effect of daikenchuto (TU-100) on gastrointestinal and colonic transit in humans. Am J Physiol Gastrointest Liver Physiol (2010) 1.32
Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study. Am J Gastroenterol (2011) 1.32
Do distinct dyspepsia subgroups exist in the community? A population-based study. Am J Gastroenterol (2007) 1.30
Morbidity and mortality among older individuals with undiagnosed celiac disease. Gastroenterology (2010) 1.29
Gastrointestinal symptoms in families of patients with an SCN5A-encoded cardiac channelopathy: evidence of an intestinal channelopathy. Am J Gastroenterol (2006) 1.27
Decreasing utilization of hysterectomy: a population-based study in Olmsted County, Minnesota, 1965-2002. Am J Obstet Gynecol (2007) 1.27
Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population. Am J Gastroenterol (2011) 1.26
Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome? Am J Physiol Gastrointest Liver Physiol (2009) 1.24
Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case-control study. Inflamm Bowel Dis (2004) 1.22
HLA DQ gene dosage and risk and severity of celiac disease. Clin Gastroenterol Hepatol (2007) 1.22
A Klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea. Gastroenterology (2011) 1.22
An assessment of the management of acute bleeding varices: a multicenter prospective member-based study. Am J Gastroenterol (2003) 1.22
Effect of aging on anorectal and pelvic floor functions in females. Dis Colon Rectum (2006) 1.21
Phenotypic variation of colonic motor functions in chronic constipation. Gastroenterology (2009) 1.20
Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol (2013) 1.20
Candidate genes and sensory functions in health and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2008) 1.19
Preventive medical services among patients with rheumatoid arthritis. J Rheumatol (2003) 1.19